These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

853 related articles for article (PubMed ID: 19164849)

  • 1. Glial cell line-derived neurotrophic factor added to a sciatic nerve fragment grafted in a spinal cord gap ameliorates motor impairments in rats and increases local axonal growth.
    Guzen FP; de Almeida Leme RJ; de Andrade MS; de Luca BA; Chadi G
    Restor Neurol Neurosci; 2009; 27(1):1-16. PubMed ID: 19164849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sciatic nerve grafting and inoculation of FGF-2 promotes improvement of motor behavior and fiber regrowth in rats with spinal cord transection.
    Guzen FP; Soares JG; de Freitas LM; Cavalcanti JR; Oliveira FG; Araújo JF; Cavalcante Jde S; Cavalcante JC; do Nascimento ES; de Oliveira Costa MS
    Restor Neurol Neurosci; 2012; 30(3):265-75. PubMed ID: 22555431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A neuroprotective role of glial cell line-derived neurotrophic factor following moderate spinal cord contusion injury.
    Iannotti C; Ping Zhang Y; Shields CB; Han Y; Burke DA; Xu XM
    Exp Neurol; 2004 Oct; 189(2):317-32. PubMed ID: 15380482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pain with no gain: allodynia following neural stem cell transplantation in spinal cord injury.
    Macias MY; Syring MB; Pizzi MA; Crowe MJ; Alexanian AR; Kurpad SN
    Exp Neurol; 2006 Oct; 201(2):335-48. PubMed ID: 16839548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
    Winkler C; Georgievska B; Carlsson T; Lacar B; Kirik D
    Neuroscience; 2006 Aug; 141(1):521-31. PubMed ID: 16697115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronically injured spinal cord with neurotrophic factors stimulates betaII-tubulin and GAP-43 expression in rubrospinal tract neurons.
    Storer PD; Dolbeare D; Houle JD
    J Neurosci Res; 2003 Nov; 74(4):502-11. PubMed ID: 14598294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor.
    Georgievska B; Carlsson T; Lacar B; Winkler C; Kirik D
    Eur J Neurosci; 2004 Dec; 20(11):3121-30. PubMed ID: 15579166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responses of reactive astrocytes containing S100beta protein and fibroblast growth factor-2 in the border and in the adjacent preserved tissue after a contusion injury of the spinal cord in rats: implications for wound repair and neuroregeneration.
    do Carmo Cunha J; de Freitas Azevedo Levy B; de Luca BA; de Andrade MS; Gomide VC; Chadi G
    Wound Repair Regen; 2007; 15(1):134-46. PubMed ID: 17244329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rescue and sprouting of motoneurons following ventral root avulsion and reimplantation combined with intraspinal adeno-associated viral vector-mediated expression of glial cell line-derived neurotrophic factor or brain-derived neurotrophic factor.
    Blits B; Carlstedt TP; Ruitenberg MJ; de Winter F; Hermens WT; Dijkhuizen PA; Claasens JW; Eggers R; van der Sluis R; Tenenbaum L; Boer GJ; Verhaagen J
    Exp Neurol; 2004 Oct; 189(2):303-16. PubMed ID: 15380481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular GDNF delivery promotes growth of motor and dorsal column sensory axons after partial and complete spinal cord transections and induces remyelination.
    Blesch A; Tuszynski MH
    J Comp Neurol; 2003 Dec; 467(3):403-17. PubMed ID: 14608602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotrophic factors expressed in both cortex and spinal cord induce axonal plasticity after spinal cord injury.
    Zhou L; Shine HD
    J Neurosci Res; 2003 Oct; 74(2):221-6. PubMed ID: 14515351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local delivery of glial cell line-derived neurotrophic factor improves facial nerve regeneration after late repair.
    Barras FM; Kuntzer T; Zurn AD; Pasche P
    Laryngoscope; 2009 May; 119(5):846-55. PubMed ID: 19266571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations.
    Neuhuber B; Timothy Himes B; Shumsky JS; Gallo G; Fischer I
    Brain Res; 2005 Feb; 1035(1):73-85. PubMed ID: 15713279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in glial cell line-derived neurotrophic factor release from biodegradable nerve conduits modify the rate of functional motor recovery after rat primary nerve repairs.
    Piquilloud G; Christen T; Pfister LA; Gander B; Papaloïzos MY
    Eur J Neurosci; 2007 Sep; 26(5):1109-17. PubMed ID: 17767490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous administration of glial cell line-derived neurotrophic factor improves recovery after spinal cord injury.
    Kao CH; Chen SH; Chio CC; Chang CK; Lin MT
    Resuscitation; 2008 Jun; 77(3):395-400. PubMed ID: 18367307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal gene delivery of glial cell line-derived neurotrophic factor ameliorated paraplegia in rats after spinal ischemia.
    Chou AK; Yang LC; Wu PC; Wong WT; Liu GS; Chen JT; Howng SL; Tai MH
    Brain Res Mol Brain Res; 2005 Feb; 133(2):198-207. PubMed ID: 15710236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal growth potential of lumbar dorsal root ganglion neurons in an organ culture system: response of nerve growth factor-sensitive neurons to neuronal injury and an inflammatory cytokine.
    Aoki Y; An HS; Takahashi K; Miyamoto K; Lenz ME; Moriya H; Masuda K
    Spine (Phila Pa 1976); 2007 Apr; 32(8):857-63. PubMed ID: 17426629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effects of glial cell line-derived neurotrophic factor on spinal cord and cortex cerebri grafts.
    Trok K; Almström S; Olson L
    J Pharmacol Exp Ther; 1996 Aug; 278(2):941-9. PubMed ID: 8768751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of lentiviral vector-mediated overexpression of nerve growth factor and glial cell line-derived neurotrophic factor on regenerating sensory and motor axons in the transected peripheral nerve.
    Tannemaat MR; Eggers R; Hendriks WT; de Ruiter GC; van Heerikhuize JJ; Pool CW; Malessy MJ; Boer GJ; Verhaagen J
    Eur J Neurosci; 2008 Oct; 28(8):1467-79. PubMed ID: 18973572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantation of bioactive growth factor-secreting rods enhances fetal dopaminergic graft survival, outgrowth density, and functional recovery in a rat model of Parkinson's disease.
    Törnqvist N; Björklund L; Almqvist P; Wahlberg L; Strömberg I
    Exp Neurol; 2000 Jul; 164(1):130-8. PubMed ID: 10877923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.